Published price vs quote-only
Shed vs altRx: Which One Publishes Its Price? (2026)
Shed quotes after intake, altRx $89/mo. What each 2026 program includes, what it omits, and which patient each one suits.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 8.7 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Shed and altRx sit at ranks 1 and 8 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
One of these programs can be evaluated before you start it and one cannot. altRx lists Semaglutide $89/mo, tirzepatide $149/mo; with Shed, Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Easier to price in advance
- altRx — Semaglutide $89/mo, tirzepatide $149/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Widest medication choice
- Shed — name-brand FDA-approved GLP-1 and compounded GLP-1.
Side-by-side comparison
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Shed | altRx | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | Semaglutide $89/mo, tirzepatide $149/mo |
| Rate after promotions | not published before intake | $89/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Shipping | Home delivery after clinician review | Free, discreet 2-day delivery |
| Payment options | Card only, no financing published | Affirm, Klarna and Afterpay |
| Tirzepatide | Not published | $149/mo |
| Support model | Coaching built into the plan | Clinician messaging included |
| Patient reviews | 8,500 | 14,820 |
| eRxDoctor score | 9.9/10 | 8.7/10 |
The real cost: six months and twelve
Both providers lead with a number designed to get you through the intake. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Shed | altRx | |
|---|---|---|
| First month | Not published | $89 |
| Months 2 onward | Not published | $89/mo |
| 6-month total | Not computable | $534 |
| 12-month total | Not computable | $1,068 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
What each one will tell you before you commit
altRx publishes Semaglutide $89/mo, tirzepatide $149/mo before intake. That is the baseline condition for comparing two programs at all.
Shed withholds the figure until 2-minute approval assessment is complete — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Whatever the reason, it moves the price conversation to after your commitment rather than before it.
The workaround is straightforward: complete Shed's assessment, get the quote, and then price it against altRx's published $89/mo before agreeing to anything.
Inside the Shed program
Shed positions itself on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it. Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month.
Getting started means 2-minute approval assessment, after which home delivery after clinician review. Pricing runs on a quoted only after intake basis, quote only, after intake.
Ongoing care is continuous coaching built into every treatment plan, and the medication list runs to name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Flexibility to choose medication type based on budget and needs
- Fast 2-minute approval assessment
- 10% off your first month for new patients
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
Shed cons
- Name-brand options carry significantly higher costs than compounded alternatives
- Coaching-bundled model can cost more than bare-prescription platforms
- Standard pricing is not published, you receive a personalized quote after intake
The reservation worth holding, particularly next to altRx: you cannot know what you will pay until you have finished the intake.
altRx: what you are buying
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery.
The process is 100% online medical visits, then free, discreet 2-day delivery. On money, expect flat rate at every dose — published upfront.
Behind the prescription sits responsive care team for ongoing clinician-guided support. Available medication: compounded semaglutide and compounded tirzepatide.
altRx pros
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
- Responsive care team for ongoing clinician-guided support
- Free and discreet 2-day delivery
- No commitment, cancel anytime
altRx cons
- Compounded medication, not FDA-approved branded product
- Not available in all U.S. states
The cost of choosing this over Shed: the rate is a limited offer and the platform does not operate in every state.
Picking between them
Choose Shed if:
- you want to start on their timeline: 2-minute approval assessment
- delivery works the way you want it to: home delivery after clinician review
- what it leads on is worth paying for in your case: one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
- the level of clinical contact suits you: continuous coaching built into every treatment plan
Choose altRx if:
- the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
- the feature you would actually use: the cheapest published tirzepatide rate on this list at $149, with the injection kit included
- delivery works the way you want it to: free, discreet 2-day delivery
- you want to start on their timeline: 100% online medical visits
The trade-offs, stated plainly
On price. Only altRx publishes a rate you can plan against (Semaglutide $89/mo, tirzepatide $149/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On access. Shed advertises 2-minute approval assessment and home delivery after clinician review; altRx advertises 100% online medical visits and free, discreet 2-day delivery. Coverage differs too — not published against not available in every state — which decides the question before price does if you are in a restricted state.
On predictability. The pricing structures differ (quoted only after intake versus flat rate at every dose), and structure, not headline rate, determines the twelve-month bill.
On clinical contact. Continuous coaching built into every treatment plan at Shed; responsive care team for ongoing clinician-guided support at altRx. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
What the evidence actually says
Neither Shed nor altRx manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
STEP 1 recorded a mean 14.9% reduction in body weight over 68 weeks on weekly semaglutide, against 2.4% for placebo, per NEJM, STEP 1.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Shed vs altRx: common questions
What happens when altRx's promotional price ends?
The rate moves to $89/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, Shed or altRx?
Only altRx publishes a first-month figure (Semaglutide $89/mo, tirzepatide $149/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to altRx, which publishes Semaglutide $89/mo, tirzepatide $149/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Is coaching included with Shed or altRx?
Shed includes continuous coaching built into every treatment plan in the monthly price. altRx provides responsive care team for ongoing clinician-guided support, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Which has more patient reviews, Shed or altRx?
altRx, with 14,820 against 8,500. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
What happens if I stop taking the medication?
Neither Shed nor altRx penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Are Shed and altRx legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Shed operates on quoted only after intake with pricing quote only, after intake, altRx on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; altRx leads on the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Shed vs NoviPublished price vs quote-only
- Shed vs Mochi HealthPublished price vs quote-only
- altRx vs He & She MDBudget vs premium
- altRx vs MaximusTirzepatide access
- Directmeds vs RefillsPublished price vs quote-only
- Directmeds vs EmbodyPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or altRx, and does not sell treatment. Read our ranking methodology.